Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-03
DOI
10.1038/s41388-018-0461-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hyperactive mTOR induces neuroendocrine differentiation in prostate cancer cell with concurrent up-regulation of IRF1
- (2017) Mayuko Kanayama et al. PROSTATE
- SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer
- (2017) Ping Mu et al. SCIENCE
- Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice
- (2016) Feng Sun et al. CARCINOGENESIS
- SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment
- (2016) Y Sun et al. ONCOGENE
- Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer
- (2016) Kristine M. Wadosky et al. Oncotarget
- A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer
- (2015) Fatima H. Karzai et al. BJU INTERNATIONAL
- Quantification of Mesenchymal Stem Cells (MSCs) at Sites of Human Prostate Cancer
- (2015) W. Nathaniel Brennen et al. Oncotarget
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
- (2014) Tomasz M. Beer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy
- (2014) Yasuyoshi Miyata et al. PROSTATE
- The E3 Ubiquitin Ligase Siah2 Contributes to Castration-Resistant Prostate Cancer by Regulation of Androgen Receptor Transcriptional Activity
- (2013) Jianfei Qi et al. CANCER CELL
- Cancer heterogeneity—a multifaceted view
- (2013) Felipe De Sousa E Melo et al. EMBO REPORTS
- The perivascular niche regulates breast tumour dormancy
- (2013) Cyrus M. Ghajar et al. NATURE CELL BIOLOGY
- A reciprocal role of prostate cancer on stromal DNA damage
- (2013) J Banerjee et al. ONCOGENE
- Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
- (2013) Nicholas Erho et al. PLoS One
- Increased serum insulin-like growth factor-1 levels are associated with prolonged response to dasatinib-based regimens in metastatic prostate cancer
- (2013) Farshid Dayyani et al. PROSTATE
- Challenges in Recognizing Treatment-Related Neuroendocrine Prostate Cancer
- (2012) Himisha Beltran et al. JOURNAL OF CLINICAL ONCOLOGY
- Endoglin Requirement for BMP9 Signaling in Endothelial Cells Reveals New Mechanism of Action for Selective Anti-Endoglin Antibodies
- (2012) Olivier Nolan-Stevaux et al. PLoS One
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Upregulation of cancer-associated myofibroblasts by TGF-β from scirrhous gastric carcinoma cells
- (2011) Y Fuyuhiro et al. BRITISH JOURNAL OF CANCER
- Role for Stromal Heterogeneity in Prostate Tumorigenesis
- (2011) M. A. Kiskowski et al. CANCER RESEARCH
- Altered TGF-β Signaling in a Subpopulation of Human Stromal Cells Promotes Prostatic Carcinogenesis
- (2011) Omar E. Franco et al. CANCER RESEARCH
- Endoglin Regulates Cancer-Stromal Cell Interactions in Prostate Tumors
- (2011) D. Romero et al. CANCER RESEARCH
- Secreted frizzled-related proteins are required for Wnt/ -catenin signalling activation in the vertebrate optic cup
- (2011) P. Esteve et al. DEVELOPMENT
- The Role of Calcineurin/NFAT in SFRP2 Induced Angiogenesis—A Rationale for Breast Cancer Treatment with the Calcineurin Inhibitor Tacrolimus
- (2011) Sharareh Siamakpour-Reihani et al. PLoS One
- Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
- (2011) H. Beltran et al. Cancer Discovery
- CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker
- (2010) Lawrence D True et al. MODERN PATHOLOGY
- Secreted Frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancer
- (2009) Y Kawano et al. BRITISH JOURNAL OF CANCER
- Tumor-promoting phenotype of CD90hiprostate cancer-associated fibroblasts
- (2009) Hongjuan Zhao et al. PROSTATE
- Stromal Transforming Growth Factor- Signaling Mediates Prostatic Response to Androgen Ablation by Paracrine Wnt Activity
- (2008) V. R. Placencio et al. CANCER RESEARCH
- Secreted frizzled related protein 1 is a paracrine modulator of epithelial branching morphogenesis, proliferation, and secretory gene expression in the prostate
- (2008) Margaret S. Joesting et al. DEVELOPMENTAL BIOLOGY
- Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease
- (2008) P. Bovolenta et al. JOURNAL OF CELL SCIENCE
- Prostate tumor progression is mediated by a paracrine TGF-β/Wnt3a signaling axis
- (2008) X Li et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started